Positions

Overview

  • Orandi comes to UAB from the University of California in San Fransisco, where he also recently completed an abdominal transplant fellowship. Orandi’s research has largely focused on incompatible kidney transplantation and antibody-mediated rejection.

    • Selected Publications

    Academic Article

    Year Title Altmetric
    2020 Impact of ABO-Incompatible Living Donor Kidney Transplantation on Patient Survival.  American Journal of Kidney Diseases.  76:616-623. 2020
    2020 Bariatric surgery to achieve transplant in end-stage organ disease patients: A systematic review and meta-analysis 2020
    2020 Combined Thoracic-Kidney Transplantation Practices May Exacerbate Existing Geographic Disparities in Access to Deceased Donor Kidney Transplantation 2020
    2020 Tackling the weight list problem.  American Journal of Transplantation.  20:329-330. 2020
    2020 Competing risks and the risks of children and adults competing for livers.  American Journal of Transplantation.  2020
    2020 Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?.  Transplantation.  1215-1228. 2020
    2019 Donation approval among obese living kidney donor candidates: The impact of metabolic syndrome.  Surgery.  166:940-946. 2019
    2019 Mitigating Racial and Sex Disparities in Access to Living Donor Kidney Transplantation: Impact of the Nation's Longest Single-center Kidney Chain.  Annals of Surgery.  270:639-646. 2019
    2019 Prediction system for risk of allograft loss in patients receiving kidney transplants: International derivation and validation study.  BMJ.  366. 2019
    2019 Assessment of Trends in Transplantation of Liver Grafts from Older Donors and Outcomes in Recipients of Liver Grafts from Older Donors, 2003-2016.  JAMA Surgery.  154:441-449. 2019
    2019 The effect of an organ procurement experience on preclinical medical student perceptions of transplant surgery.  Clinical Transplantation.  33. 2019
    2019 Banff survey on antibody-mediated rejection clinical practices in kidney transplantation: Diagnostic misinterpretation has potential therapeutic implications.  American Journal of Transplantation.  19:123-131. 2019
    2018 Utilization, patency, and complications associated with vascular access for hemodialysis in the United States.  Journal of Vascular Surgery.  68:1166-1174. 2018
    2018 Transfusion of leukoreduced blood products and risk of antibody-mediated rejection of renal allografts.  Transfusion.  58:1951-1957. 2018
    2018 Intraoperative Management of Liver Transplant Patients Without the Routine Use of Renal Replacement Therapy.  Transplantation.  102:e229-e235. 2018
    2018 Surgical approach, cost, and complications of appendectomy in kidney transplant recipients.  Clinical Transplantation.  32. 2018
    2018 Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study.  American Journal of Transplantation.  18:650-658. 2018
    2018 Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment.  Journal of the American Society of Nephrology.  29:620-635. 2018
    2017 The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis.  American Journal of Transplantation.  17:3123-3130. 2017
    2017 Ureteral Obstruction and New Groin Pain in a Kidney Transplant Recipient.  American Journal of Transplantation.  17:1139-1141. 2017
    2017 The Dawn of Transparency: Insights from the Physician Payment Sunshine Act in Plastic Surgery.  Annals of Plastic Surgery.  78:315-323. 2017
    2017 Here Comes the Sunshine: Industry's Payments to Cardiothoracic Surgeons.  Annals of Thoracic Surgery.  103:567-572. 2017
    2017 The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.  American Journal of Transplantation.  17:28-41. 2017
    2016 Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study.  American Journal of Transplantation.  16:3468-3478. 2016
    2016 Mortality and Rates of Graft Rejection or Failure Following Intestinal Transplantation in Patients With vs Without Crohn's Disease.  Clinical Gastroenterology and Hepatology.  14:1574-1581. 2016
    2016 Recurrent IgA Nephropathy After Kidney Transplantation.  Transplantation Proceedings.  48:2689-2694. 2016
    2016 Splenic irradiation for the treatment of severe antibody-mediated rejection.  American Journal of Transplantation.  16:3041-3045. 2016
    2016 Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus.  American Journal of Transplantation.  16:2368-2376. 2016
    2016 The authors reply.  New England Journal of Medicine.  375:288-289. 2016
    2016 Long-Term Renal Function in Living Kidney Donors Who Had Histological Abnormalities at Donation.  Transplantation.  100:1294-1298. 2016
    2016 Economic Impacts of ABO-Incompatible Live Donor Kidney Transplantation: A National Study of Medicare-Insured Recipients.  American Journal of Transplantation.  16:1465-1473. 2016
    2016 Survival benefit with kidney transplants from HLA-incompatible live donors.  New England Journal of Medicine.  374:940-950. 2016
    2016 Presentation and outcomes of C4d-negative antibody-mediated rejection after kidney transplantation.  American Journal of Transplantation.  16:213-220. 2016
    2016 Where the Sun shines: Industry's payments to transplant surgeons.  American Journal of Transplantation.  16:292-300. 2016
    2015 Choosing the order of deceased donor and living donor kidney transplantation in pediatric recipients: A Markov decision process model.  Transplantation.  99:360-366. 2015
    2015 A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation.  Kidney International.  87:409-416. 2015
    2015 Center-level variation in the development of delayed graft function after deceased donor kidney transplantation.  Transplantation.  99:997-1002. 2015
    2015 Frailty and mortality in kidney transplant recipients.  American Journal of Transplantation.  15:149-154. 2015
    2015 Frailty, mycophenolate reduction, and graft loss in kidney transplant recipients.  Transplantation.  99:805-810. 2015
    2015 Loss of pediatric kidney grafts during the "high-risk age window": Insights from pediatric liver and simultaneous liver-kidney recipients.  American Journal of Transplantation.  15:445-452. 2015
    2015 Quantifying renal allograft loss following early antibody-mediated rejection.  American Journal of Transplantation.  15:489-498. 2015
    2014 Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation.  American Journal of Transplantation.  14:459-465. 2014
    2014 Assessment of resident and fellow knowledge of the organ donor referral process.  Clinical Transplantation.  28:443-449. 2014
    2014 Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation.  Transplantation.  98:857-863. 2014
    2014 National trends over 25 years in pediatric kidney transplant outcomes.  Pediatrics.  133:594-601. 2014
    2014 Outcomes of nonelective weekend admissions for lower extremity ischemia.  Journal of Vascular Surgery.  60:1572-1579.e1. 2014
    2014 Patient- And Provider-Reported Information about Transplantation and Subsequent Waitlisting.  Journal of the American Society of Nephrology.  25:2871-2877. 2014
    2014 Quantifying the risk of incompatible kidney transplantation: A multicenter study.  American Journal of Transplantation.  14:1573-1580. 2014
    2013 Order of donor type in pediatric kidney transplant recipients requiring retransplantation.  Transplantation.  96:487-493. 2013
    2013 Age at graft loss after pediatric kidney transplantation: Exploring the high-risk age window.  Clinical Journal of the American Society of Nephrology.  8:1019-1026. 2013
    2013 The aggressive phenotype revisited: Utilization of higher-risk liver allografts.  American Journal of Transplantation.  13:936-942. 2013
    2011 Surgical mentors' and mentees' productivity from 1993 to 2006 2011
    2011 Ethics and the law: Is there common ground on informed consent for disparities in hospital outcomes?.  Annals of Internal Medicine.  155:260-264. 2011
    2010 Development of "Imageable" Beads for Transcatheter Embolotherapy 2010
    2009 A population-based analysis of endovascular versus open thoracic aortic aneurysm repair.  Journal of Vascular Surgery.  49:1112-1116. 2009
    2009 The escalating importance of clinical research.  The virtual mentor : VM.  11:277-278. 2009

    Chapter

    Year Title Altmetric
    2013 Complications of endovascular aneurysm repair.  90-101. 2013
    2012 Acute mesenteric ischemia.  426-430. 2012
    2012 Know what to look for when patients with post-ercp complications present to the emergency department.  25-27. 2012

    Education And Training

  • Doctor of Medicine, University of Michigan 2008

    • Full Name

  • Babak Orandi